Rate of development of mutation at codon 215 of HIV-1 reverse transcriptase and its predictive factors at the time of initiation of zidovudine therapy-Reference-Cited by-同舟云学术

Rate of development of mutation at codon 215 of HIV-1 reverse transcriptase and its predictive factors at the time of initiation of zidovudine therapy

Published:1996-06 Issue:6 Volume:26 Page:476-480
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

LEAL M.,REY C.,TORRES Y.,RELIMPIO F.,PINO R.,LISSEN E.,SANCHEZ-QUIJANO A.,LUQUE F.

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2362.1996.164315.x/fullpdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency of Mutations Conferring Resistance to Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Patients in Korea;Journal of Clinical Microbiology;2002-04

2. Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed;International Immunopharmacology;2001-07

3. Usefulness of route of transmission, absolute CD8+T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4+T-cell counts;European Journal of Clinical Microbiology and Infectious Diseases;2001-05-08

4. Low Levels of HIV-1 Plasma Viral Load in Patients Infected with HIV-1 Subtype B and Advanced Immunosuppression;Journal of Infection;2001-01

5. Phase II, Randomized, Open-Label, Community-Based Trial to Compare the Safety and Activity of Combination Therapy With Recombinant Interferon-α2b and Zidovudine Versus Zidovudine Alone in Patients With Asymptomatic to Mildly Symptomatic HIV Infection;Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology;1999-03